Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.8%

4 terminated/withdrawn out of 106 trials

Success Rate

92.2%

+5.6% vs industry average

Late-Stage Pipeline

18%

19 trials in Phase 3/4

Results Transparency

6%

3 of 47 completed trials have results

Key Signals

13 recruiting3 with results

Enrollment Performance

Analytics

N/A
32(50.0%)
Phase 4
16(25.0%)
Phase 2
12(18.8%)
Phase 3
3(4.7%)
Phase 1
1(1.6%)
64Total
N/A(32)
Phase 4(16)
Phase 2(12)
Phase 3(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (106)

Showing 20 of 106 trials
NCT07796217Phase 4Recruiting

Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy

Role: collaborator

NCT05578274Not ApplicableWithdrawn

Abscopal Effect From Low-dose Radiotherapy in Metastatic Cancer Combined With Stereotactic Body Radiotherapy

Role: lead

NCT06144125Phase 4Recruiting

Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery

Role: collaborator

NCT07577882Not Yet Recruiting

Cross-cultural Differences In Sleep Patterns And Problems in Asian School-aged Adolescents: The ACROSS Study

Role: collaborator

NCT07606430Not ApplicableNot Yet Recruiting

Comparison of a Short Modified Metal Stent Versus Plastic Stent as a Bridge to Surgery in Pancreatic Cancer With Malignant Biliary Obstruction

Role: lead

NCT07488611Phase 3Recruiting

PROGAIN Trial in Gastric Cancer Surgery

Role: lead

NCT07497867Recruiting

Long-term Prospective Study of Korean CADASIL Patients

Role: collaborator

NCT06141798Not ApplicableRecruiting

Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients

Role: lead

NCT06950489Completed

Tegoprazan and Amoxicillin Dual Therapy

Role: lead

NCT06682533Recruiting

Tegoprazan- Versus PPI-based H. Pylori Eradication

Role: lead

NCT06684860Completed

RUT vs. Molecular Testing for H. Pylori

Role: lead

NCT04014803Phase 4Recruiting

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Role: collaborator

NCT05257824Phase 4Completed

Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling

Role: collaborator

NCT07241143Not ApplicableNot Yet Recruiting

Extra-Peritoneal Tunneling Versus Conventional Drain Fixation After Anterior or Low Anterior Resection

Role: collaborator

NCT07213596Not ApplicableNot Yet Recruiting

Virtual Reality Treatment for Trauma Related to COVID-19 Infection

Role: lead

NCT06431737Completed

Comparison of Twice- and Four-times-daily Amoxicillin Administration in 2-week Tegoprazan-based H. Pylori Eradication

Role: lead

NCT06903429Not ApplicableNot Yet Recruiting

Using LUminoMark vs Coventional Practice for Targeted Axillary Surgery

Role: collaborator

NCT06889818Recruiting

Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)

Role: collaborator

NCT06782984Recruiting

Drug Response Testing and Repurposing Using Glioblastoma Organoid

Role: collaborator

NCT05733156Not ApplicableRecruiting

Abscopal Effect from the Low-dose Radiotherapy in Polymetastatic Cancer Patients Receiving Stereotactic Radiotherapy

Role: lead